Articulatory Adaptation Following Oral Cancer Treatment
NCT ID: NCT05876247
Last Updated: 2023-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-11-10
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will perform multiple speech tasks while motion tracking sensors track the articulatory gestures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging
NCT00594724
Handheld Dynamometer During Awake Craniotomy Pilot
NCT04742231
Long Term Complications in Head and Neck Cancer Patients
NCT04257968
The Feasibility of Multispectral Optoacoustic Tomography in Different Diseases
NCT06740175
Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery
NCT02165995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals treated for oral cancer
Dutch native speakers (18+) who will undergo surgical treatment for a T1 or T2 tumour on the tongue.
Electromagnetic Articulography
Motion tracking sensors will track articulatory movements of the tongue, jaw and lips
Control speakers
Dutch native speakers (18+) without self-reported speech problems.
Electromagnetic Articulography
Motion tracking sensors will track articulatory movements of the tongue, jaw and lips
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electromagnetic Articulography
Motion tracking sensors will track articulatory movements of the tongue, jaw and lips
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. At least 18 years old and able to provide informed consent
3. Native speaker of Dutch
4. Has nog been treated for oral cancer before
Exclusion Criteria
1b. Treated for oral cancer (for healthy controls) 2. Speech problems (e.g., stuttering) 3. Problems with sight or hearing that impede reading or understanding instructions. When glasses or a hearing aid resolve these problems, then participants are not excluded.
4\. Neurological or psychological disorders (e.g., stroke) 5. Non-removable metal in, on or around the head (piercings, braces, pacemaker, electrodes) 6. Self-reported signs of depression
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Max Witjes, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Groningen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Arts, University of Groningen
Groningen, , Netherlands
University Medical Centre Groningen
Groningen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METc 2021/711
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.